The Drug Enforcement Administration on Thursday said it would tighten control of hydrocodone combination drugs by rescheduling them from Schedule III to Schedule II. The change means prescriptions for such drugs can cover only a 90-day period instead of the previous 180 days. "Today's action recognizes that these products are some of the most addictive and potentially dangerous prescription medications available," DEA Administrator Michele Leonhart said.

Related Summaries